More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$6.23B
EPS
8.53
P/E ratio
--
Price to sales
3.25
Dividend yield
0.866%
Beta
0.855404
Previous close
$155.10
Today's open
$155
Day's range
$154.63 - $157.65
52 week range
$100.18 - $157.65
show more
CEO
Stuart Randle
Employees
15500
Headquarters
Wayne, PA
Exchange
New York Stock Exchange
Shares outstanding
39661261
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Teleflex: The Market Is Pricing The Transition, Not The Company Coming Out Of It
Teleflex is undergoing a portfolio overhaul, with future earnings driven by cost cuts, deleveraging, and share buybacks rather than top-line growth. TFX's adjusted gross margin reached 66.8% in Q3; management raised 2026 adjusted EPS guidance to $7.50–$7.75, viewing this as a minimum. Freesolve and Ezplaz offer significant growth optionality, with Freesolve expanding in the U.S. and Ezplaz targeting a $200M+ market opportunity.
Seeking Alpha • Nov 13, 2026

Teleflex to Present at the Jefferies Global Healthcare Conference in London
WAYNE, Pa.--(BUSINESS WIRE)--Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026, at 12:00 p.m. (GMT). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at teleflex.com. About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's l.
Business Wire • Nov 11, 2026

Teleflex Q3 Earnings Call Highlights
Teleflex NYSE: TFX raised its 2026 adjusted earnings outlook after reporting higher third-quarter earnings and a return to growth in its Interventional business, although the company said a planned divestiture could close later than expected.
MarketBeat • Nov 8, 2026

Teleflex Incorporated (TFX) Q3 2026 Earnings Call Transcript
Teleflex Incorporated (TFX) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 5, 2026

Teleflex Reports Third Quarter Financial Results and Full Year 2026 Outlook
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 30, 2026. Third quarter 2026 continuing operations financial summary1 Revenue from continuing operations of $567.8 million, up 0.2% compared to the prior year period, and up 3.0% on a pro forma adjusted constant currency basis1,2 GAAP diluted EPS from continuing operations of $1.30, compared to $(1.32) in the prior year period Adjusted diluted EP.
Business Wire • Nov 5, 2026

Teleflex Announces Quarterly Dividend
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 31, 2026, to shareholders of record at the close of business on November 16, 2026.About Teleflex IncorporatedAs a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to becom.
Business Wire • Nov 5, 2026

Teleflex (TFX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks Investment Research • Nov 5, 2026

Teleflex (TFX) Q3 Earnings Surpass Estimates
Teleflex (TFX) came out with quarterly earnings of $2.63 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $3.67 per share a year ago.
Zacks Investment Research • Nov 5, 2026

Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 5, 2026. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company's website, teleflex.com. An audio replay of the call will be available beginning.
Business Wire • Oct 22, 2026

Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) for its Freesolve™ Resorbable Magnesium Scaffold (RMS) for percutaneous coronary intervention (PCI). To qualify for a BDD, device technology must address an unmet clinical need and show that it has the potential to provide for more effective treatment of life-threateni.
Business Wire • Oct 22, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Teleflex Incorporated commission-free¹. Build wealth for the long term using automated trading and transfers.